DBN1 and Alzheimer disease: Interestingly, post-mortem studies have reported decreased drebrin levels in the temporal cortex and increased levels in the frontal cortex of patients with mild cognitive impairment, suggesting a disparity in postsynaptic efficacy in these regions during the onset of Alzheimer’s disease.